Entecavir hydrate, 2 g

Its efficacy lies in its ability to selectively inhibit viral DNA polymerase, thus reducing the viral load. This targeted approach minimizes side effects while maximizing therapeutic outcomes.

Performance You Can Count On

Formulated into a crystalline powder, Entecavir Hydrate, 2 G offers a precise delivery mechanism for healthcare professionals. This powder form ensures accurate dosing and reduces the risk of contamination during administration.

Common Application Settings

• Recommended for use in clinical settings where rapid antiviral response is critical.
• Packaged in 2-g quantities, ideal for small-scale research or individual patient treatment.
• Compatible with standard laboratory equipment for convenient reconstitution.
• Suitable for use in combination with other antiviral therapies under medical supervision.
• Supports ongoing research in virology and antiviral medicine.